257
Views
152
CrossRef citations to date
0
Altmetric
Research Article

Novel Aspects of Blood Coagulation Factor XIII. I. Structure, Distribution, Activation, and Function

, &
Pages 357-421 | Published online: 27 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Aida Inbal. (2013) Recombinant factor XIII and congenital factor XIII deficiency: an update from human and animal studies. Research Reports in Clinical Cardiology 4, pages 159-165.
Read now
Zehra Fadoo, Quratulain Merchant & Karim Abdur Rehman. (2013) New developments in the management of congenital Factor XIII deficiency. Journal of Blood Medicine 4, pages 65-73.
Read now
Ángel López-Cuenca, Francisco Marín, Vanessa Roldán, Rocío González-Conejero, Diana Hernández-Romero, Mariano Valdés & Gregory Y. H. Lip. (2010) Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk. Annals of Medicine 42:8, pages 562-575.
Read now
Keith E Steele, Arthur O Anderson & Mansour Mohamadzadeh. (2009) Fibroblastic reticular cells and their role in viral hemorrhagic fevers. Expert Review of Anti-infective Therapy 7:4, pages 423-435.
Read now
Wei Zhang, Atsushi Shiraishi, Atsushi Suzuki, Xiaodong Zheng, Toshio Kodama & Yuichi Ohashi. (2004) Expression and distribution of tissue transglutaminase in normal and injured rat cornea. Current Eye Research 28:1, pages 37-45.
Read now
Daniel Aeschlimann & Vilmos Thomazy. (2000) Protein Crosslinking in Assembly and Remodelling of Extracellular Matrices: The Role of Transglutaminases. Connective Tissue Research 41:1, pages 1-27.
Read now
E. Cario, H. Goebell, A. U. Dignass. (1999) Factor XIII Modulates Intestinal Epithelial Wound Healing in Vitro. Scandinavian Journal of Gastroenterology 34:5, pages 485-490.
Read now

Articles from other publishers (144)

Masayoshi Souri, Tatsuhiko Ozawa, Tsukasa Osaki, Takatoshi Koyama, Atsushi Muraguchi & Akitada Ichinose. (2023) Cloning of human anti-factor XIII monoclonal antibody dissects mechanisms of polyclonal antibodies in a single patient. Journal of Thrombosis and Haemostasis 21:2, pages 255-268.
Crossref
Kristina Siemens, Beverley J. Hunt, Kiran Parmar, Dan Taylor, Caner Salih & Shane M. Tibby. (2023) Factor XIII levels, clot strength, and impact of fibrinogen concentrate in infants undergoing cardiopulmonary bypass: a mechanistic sub-study of the FIBCON trial. British Journal of Anaesthesia 130:2, pages 175-182.
Crossref
Stefan Hofer, Christoph J. Schlimp, Sebastian Casu & Elisavet Grouzi. (2021) Management of Coagulopathy in Bleeding Patients. Journal of Clinical Medicine 11:1, pages 1.
Crossref
Petro H. Rautenbach, Cornelie Nienaber-Rousseau, Zelda de Lange-Loots & Marlien Pieters. (2021) Certain Associations Between Iron Biomarkers and Total and γ' Fibrinogen and Plasma Clot Properties Are Mediated by Fibrinogen Genotypes. Frontiers in Nutrition 8.
Crossref
Sebastian Casu. (2021) Simplified treatment algorithm for the management of trauma-induced hemorrhage without viscoelastic testing. Trauma Surgery & Acute Care Open 6:1, pages e000779.
Crossref
Fahad S. M. Alshehri, Claire S. Whyte & Nicola J. Mutch. (2021) Factor XIII-A: An Indispensable “Factor” in Haemostasis and Wound Healing. International Journal of Molecular Sciences 22:6, pages 3055.
Crossref
Alexis N. Orr, Janice M. Thompson, Janae M. Lyttle & Stephanie W. Watts. (2021) Transglutaminases Are Active in Perivascular Adipose Tissue. International Journal of Molecular Sciences 22:5, pages 2649.
Crossref
Fatma ŞİMŞEK, Mustafa CEYLAN & Nuray BİLGE. (2019) Serebral Venöz Trombozlu Erişkinlerde Etiyoloji ve Genetik Polimorfizm İlişkisiThe Relationship Between Etiology and Genetic Polymorphism in Adults with Cerebral Venous Thrombosis. Düzce Tıp Fakültesi Dergisi 21:3, pages 166-171.
Crossref
Kayo Sugitani, Kazuhiro Ogai, Haruka Muto, Keisuke Onodera, Ayaka Matsuoka, Takahira Sugita & Yoshiki Koriyama. (2019) A novel activation mechanism of cellular Factor XIII in zebrafish retina after optic nerve injury. Biochemical and Biophysical Research Communications 517:1, pages 57-62.
Crossref
Ying‐Ying Hey, Terence J. O’Neill & Helen C. O’Neill. (2019) A novel myeloid cell in murine spleen defined through gene profiling. Journal of Cellular and Molecular Medicine 23:8, pages 5128-5143.
Crossref
. 2019. Cardiovascular Disease. Cardiovascular Disease 415 510 .
Claudio Tabolacci, Angelo De Martino, Carlo Mischiati, Giordana Feriotto & Simone Beninati. (2019) The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression. Medical Sciences 7:2, pages 19.
Crossref
Xueqin Chen, Jingyi Tan, Mengqi Yang, Zhi-Kai Liao, Cheng Lu, Youwei Huang & Liang-Cai Wu. (2018) Genistein has the function of alleviating and treating disseminated intravascular coagulation caused by lipopolysaccharide. Journal of Natural Medicines 72:4, pages 846-856.
Crossref
Bettina Kárai, Zsuzsanna Hevessy, Eszter Szánthó, László Csáthy, Anikó Ujfalusi, Katalin Gyurina, István Szegedi, János Kappelmayer & Csongor Kiss. (2017) Expression of Coagulation Factor XIII Subunit A Correlates with Outcome in Childhood Acute Lymphoblastic Leukemia. Pathology & Oncology Research 24:2, pages 345-352.
Crossref
Stephen R. Baker & Robert A.S. Ariëns. 2018. Cardiovascular Thrombus. Cardiovascular Thrombus 31 49 .
Akbar Dorgalaleh, Alessandro Casini & Parvin Rahmani. 2018. Congenital Bleeding Disorders. Congenital Bleeding Disorders 163 181 .
Akbar Dorgalaleh, Majid Naderi & Majid Safa. 2018. Congenital Bleeding Disorders. Congenital Bleeding Disorders 307 324 .
Kayo Sugitani, Yoshiki Koriyama, Kazuhiro Ogai, Ayako Furukawa & Satoru Kato. 2018. Retinal Degenerative Diseases. Retinal Degenerative Diseases 387 393 .
Ejaife O. Agbani & Alastair W. Poole. (2017) Procoagulant platelets: generation, function, and therapeutic targeting in thrombosis. Blood 130:20, pages 2171-2179.
Crossref
Makoto Ikejiri, Hideo Wada, Yuki Kamimoto, Kaname Nakatani & Tomoaki Ikeda. (2016) Protection From Pregnancy Loss in Women With Hereditary Thrombophilia When Associated With Fibrinogen Polymorphism Thr331Ala. Clinical and Applied Thrombosis/Hemostasis 23:5, pages 494-495.
Crossref
Kiruphagaran Thangaraju, Róbert Király, Máté A. Demény, János András Mótyán, Mónika Fuxreiter & László Fésüs. (2017) Genomic variants reveal differential evolutionary constraints on human transglutaminases and point towards unrecognized significance of transglutaminase 2. PLOS ONE 12:3, pages e0172189.
Crossref
Navina L. Chrobok, Claudia Sestito, Micha M. M. Wilhelmus, Benjamin Drukarch & Anne-Marie van Dam. (2016) Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?. Amino Acids 49:3, pages 441-452.
Crossref
Yuki Kamimoto, Hideo Wada, Makoto Ikejiri, Kaname Nakatani, Takashi Sugiyama, Kazuhiro Osato, Nao Murabayashi, Koji Habe, Hitoshi Mizutani, Takeshi Matsumoto, Kohshi Ohishi & Tomoaki Ikeda. (2016) Hypofibrinogenemia and the α-Fibrinogen Thr312Ala Polymorphism may be Risk Factors for Early Pregnancy Loss. Clinical and Applied Thrombosis/Hemostasis 23:1, pages 52-57.
Crossref
J. Fareed & O. Iqbal. 2017. Diagnostic Molecular Pathology. Diagnostic Molecular Pathology 473 483 .
E. H. Adam, S. Kreuer, K. Zacharowski, C. F. Weber & R. Wildenauer. (2016) Gerinnungsfaktor XIIIFactor XIII. Der Anaesthesist 66:1, pages 52-59.
Crossref
Lava A.T. Sharief, Andrew S. Lawrie, Ian J. Mackie, Susan Halimeh, Guenther Kappert, Colette Smith, Flora Peyvandi & Rezan A. Kadir. (2016) Plasma factor XIII level variations during menstrual cycle. Blood Coagulation & Fibrinolysis 27:7, pages 786-790.
Crossref
Andrea Beyerle, Cristina Solomon, Gerhard Dickneite & Eva Herzog. (2016) Nonclinical analysis of the safety, pharmacodynamics, and pharmacokinetics of plasma‐derived human FXIII concentrate in animals . Pharmacology Research & Perspectives 4:2.
Crossref
Leo A. Bockeria, Natalia N. Samsonova, Ivan A. Yurlov, Ludmila G. Klimovich, Elena F. Kozar, Eva H. N. Olsen & Sergey B. Zaets. (2014) Dynamics of Factor XIII Levels After Open Heart Surgery for Congenital Heart Defects: Do Cyanotic and Acyanotic Patients Differ?. Pediatric Cardiology 35:7, pages 1108-1115.
Crossref
D. Töröcsik, H. Bárdos, Zs. Hatalyák, B. Dezső, G. Losonczy, L. Paragh, Z. Péter, M. Balázs, E. Remenyik & R. Ádány. (2014) Detection of factor XIII-A is a valuable tool for distinguishing dendritic cells and tissue macrophages in granuloma annulare and necrobiosis lipoidica. Journal of the European Academy of Dermatology and Venereology 28:8, pages 1087-1096.
Crossref
Diane Nugent & Loan Hsieh. 2014. Textbook of Hemophilia. Textbook of Hemophilia 436 444 .
Mariely Navarrete, Jocelyn García, Nicolás Dutzan, Leslie Henríquez, Javier Puente, Paola Carvajal, Marcela Hernandez & Jorge Gamonal. (2014) Interferon-γ, Interleukins-6 and -4, and Factor XIII-A as Indirect Markers of the Classical and Alternative Macrophage Activation Pathways in Chronic Periodontitis. Journal of Periodontology 85:5, pages 751-760.
Crossref
L. T. Sharief, A. S. Lawrie, I. J. Mackie, C. Smith, F. Peyvandi & R. A. Kadir. (2014) Changes in factor XIII level during pregnancy. Haemophilia 20:2, pages e144-e148.
Crossref
Anita TahlanJasmina Ahluwalia. (2014) Factor XIII: Congenital Deficiency Factor XIII, Acquired Deficiency, Factor XIII A-Subunit, and Factor XIII B-Subunit. Archives of Pathology & Laboratory Medicine 138:2, pages 278-281.
Crossref
Sergey B. Zaets, Da-Zhong Xu, Qi Lu, Eleonora Feketova, Tamara L. Berezina, Inga V. Malinina, Edwin A. Deitch & Eva H.N. Olsen. (2014) Does Recombinant Factor XIII Eliminate Early Manifestations of Multiple-Organ Injury After Experimental Burn Similarly to Gut Ischemia-Reperfusion Injury or Trauma-Hemorrhagic Shock?. Journal of Burn Care & Research 35:4, pages 328-336.
Crossref
Hidehiko Kikuchi, Futoshi Kuribayashi & Shinobu Imajoh-Ohmi. (2014) Down-regulation of Fas-mediated apoptosis by plasma transglutaminase factor XIII that catalyzes fetal-specific cross-link of the Fas molecule. Biochemical and Biophysical Research Communications 443:1, pages 13-17.
Crossref
Satoru Kato, Toru Matsukawa, Yoshiki Koriyama, Kayo Sugitani & Kazuhiro Ogai. (2013) A molecular mechanism of optic nerve regeneration in fish: The retinoid signaling pathway. Progress in Retinal and Eye Research 37, pages 13-30.
Crossref
Kornelia Hardes, M. Zouhir Hammamy & Torsten Steinmetzer. (2013) Synthesis and characterization of novel fluorogenic substrates of coagulation factor XIII-A. Analytical Biochemistry 442:2, pages 223-230.
Crossref
C. Soendergaard, P.H. Kvist, J.B. Seidelin & O.H. Nielsen. (2013) Tissue-regenerating functions of coagulation factor XIII. Journal of Thrombosis and Haemostasis 11:5, pages 806-816.
Crossref
Angela M. Carter, Kristina F. Standeven & Peter J. Grant. 2013. Emery and Rimoin's Principles and Practice of Medical Genetics. Emery and Rimoin's Principles and Practice of Medical Genetics 1 20 .
Alane Beatriz Vermelho, Eliane Ferreira Noronha, Edivaldo Ximenes Ferreira Filho, Maria Antonieta Ferrara & Elba Pinto S. Bon. 2013. The Prokaryotes. The Prokaryotes 213 240 .
M. Navarrete, J. García-Sesnich, N. Dutzan, L. Henríquez, J. Puente & J. Gamonal. (2012) Presencia de marcadores de las vías de activación de los macrófagos en periodontitis crónica. Revista Clínica de Periodoncia, Implantología y Rehabilitación Oral 5:3, pages 131-134.
Crossref
David A Bender. 2012. Amino Acid Metabolism. Amino Acid Metabolism 377 429 .
Kayo Sugitani, Kazuhiro Ogai, Kiyotaka Hitomi, Kayo Nakamura-Yonehara, Takafumi Shintani, Masaharu Noda, Yoshiki Koriyama, Hideji Tanii, Toru Matsukawa & Satoru Kato. (2012) A distinct effect of transient and sustained upregulation of cellular factor XIII in the goldfish retina and optic nerve on optic nerve regeneration. Neurochemistry International 61:3, pages 423-432.
Crossref
Joanna-Marie Howes, Victoria R Richardson, Kerrie A Smith, Verena Schroeder, Riyaz Somani, Anna Shore, Katharina Hess, Ramzi Ajjan, Richard J Pease, Jeffrey N Keen, Kristina F Standeven & Angela M Carter. (2012) Complement C3 is a novel plasma clot component with anti-fibrinolytic properties. Diabetes and Vascular Disease Research 9:3, pages 216-225.
Crossref
Ágnes Simon, Zsuzsa Bagoly, Zsuzsanna Hevessy, László Csáthy, Éva Katona, György Vereb, Anikó Ujfalusi, László Szerafin, László Muszbek & János Kappelmayer. (2012) Expression of coagulation factor XIII subunit A in acute promyelocytic leukemia. Cytometry Part B: Clinical Cytometry 82B:4, pages 209-216.
Crossref
Kyle B. JohnsonHumphrey Petersen-JonesJanice M. ThompsonKiyotaka HitomiMiho ItohErik N. T. P. Bakker, Gail V. W. Johnson, Gozde Colak & Stephanie W. Watts. (2012) Vena cava and aortic smooth muscle cells express transglutaminases 1 and 4 in addition to transglutaminase 2. American Journal of Physiology-Heart and Circulatory Physiology 302:7, pages H1355-H1366.
Crossref
Jeffrey I. Weitz, John W. Eikelboom & Meyer Michel Samama. (2012) New Antithrombotic Drugs. Chest 141:2, pages e120S-e151S.
Crossref
László Muszbek, Zsuzsanna Bereczky, Zsuzsa Bagoly, István Komáromi & Éva Katona. (2011) Factor XIII: A Coagulation Factor With Multiple Plasmatic and Cellular Functions. Physiological Reviews 91:3, pages 931-972.
Crossref
Sergey B. Zaets, Da-Zhong Xu, Qi Lu, Eleonora Feketova, Tamara L. Berezina, Inga V. Malinina, Edwin A. Deitch & Eva H. Olsen. (2011) Recombinant Factor XIII Mitigates Hemorrhagic Shock-Induced Organ Dysfunction. Journal of Surgical Research 166:2, pages e135-e142.
Crossref
Amy L. Cilia La Corte, Helen Philippou & Robert A.S. Ariëns. 2011. Protein Structure and Diseases. Protein Structure and Diseases 75 127 .
Dirkjan Schokker, Mari A. Smits, Arjan J.W. Hoekman, Henk K. Parmentier & Johanna M.J. Rebel. (2010) Effects of Salmonella on spatial-temporal processes of jejunal development in chickens. Developmental & Comparative Immunology 34:10, pages 1090-1100.
Crossref
Diane Nugent & Loan Hsieh. 2010. Textbook of Hemophilia. Textbook of Hemophilia 362 368 .
Zhi Xu, Haifeng Xu, Victoria A. Ploplis & Francis J. Castellino. (2010) Factor VII Deficiency Impairs Cutaneous Wound Healing in Mice. Molecular Medicine 16:5-6, pages 167-176.
Crossref
Wolfgang Korte. (2010) F. XIII in perioperative coagulation management. Best Practice & Research Clinical Anaesthesiology 24:1, pages 85-93.
Crossref
Charikleia Spyridon Vrettou, Lampis C. Stavrinou, Spyridon Halikias, Magdalini Kyriakopoulou, Spyridon Kollias, George Stranjalis & Antonia Koutsoukou. (2009) Factor XIII deficiency as a potential cause of supratentorial haemorrhage after posterior fossa surgery. Acta Neurochirurgica 152:3, pages 529-532.
Crossref
Kohji KasaharaMasayoshi Souri, Mizuho KanedaToshiaki MikiNaomasa Yamamoto & Akitada Ichinose. (2010) Impaired clot retraction in factor XIII A subunit–deficient mice. Blood 115:6, pages 1277-1279.
Crossref
Murat Vural, Coskun Yarar, Ramazan Durmaz & Metin Ant Atasoy. (2010) Spontaneous Acute Subdural Hematoma and Chronic Epidural Hematoma in a Child with F XIII Deficiency. The Journal of Emergency Medicine 38:1, pages 25-29.
Crossref
V. Schroeder & H.-P. Kohler. 2010. Hämostaseologie. Hämostaseologie 219 225 .
Pierre Morange, Nawel Trigui, Corinne Frère, Hervé Chambost, Catherine Pouymayou, Marion Uters, Catherine Boucly, Irène Juhan-Vague & Philippe de Mazancourt. (2009) Molecular characterization of a novel mutation in the factor XIII a subunit gene associated with a severe defect: importance of prophylactic substitution. Blood Coagulation & Fibrinolysis 20:7, pages 605-606.
Crossref
Sergey B. Zaets, Da-Zhong Xu, Qi Lu, Eleonora Feketova, Tamara L. Berezina, Maryann Gruda, Inga V. Malinina, Edwin A. Deitch & Eva H. N. Olsen. (2009) RECOMBINANT FACTOR XIII DIMINISHES MULTIPLE ORGAN DYSFUNCTION IN RATS CAUSED BY GUT ISCHEMIA-REPERFUSION INJURY. Shock 31:6, pages 622-627.
Crossref
A. Lentini, B. Provenzano, C. Tabolacci & S. Beninati. (2008) Protein–polyamine conjugates by transglutaminase 2 as potential markers for antineoplastic screening of natural compounds. Amino Acids 36:4, pages 701-708.
Crossref
Xionghui Lin, Kenneth Söderhäll & Irene Söderhäll. (2008) Transglutaminase activity in the hematopoietic tissue of a crustacean, Pacifastacus leniusculus, importance in hemocyte homeostasis. BMC Immunology 9:1.
Crossref
Valentina Pietroni, Sabrina Di Giorgi, Andrea Paradisi, Bijan Ahvazi, Eleonora Candi & Gerry Melino. (2008) Inactive and Highly Active, Proteolytically Processed Transglutaminase-5 in Epithelial Cells. Journal of Investigative Dermatology 128:12, pages 2760-2766.
Crossref
F. PEYVANDI, M. CATTANEO, A. INBAL, P. DE MOERLOOSE & M. SPREAFICO. (2008) Rare bleeding disorders. Haemophilia 14:s3, pages 202-210.
Crossref
Jeffrey I. Weitz, Jack Hirsh & Meyer M. Samama. (2008) New Antithrombotic Drugs. Chest 133:6, pages 234S-256S.
Crossref
Leslie Roy Berry & Anthony Kam Chuen Chan. 2008. Biomaterials Fabrication and Processing Handbook. Biomaterials Fabrication and Processing Handbook 535 572 .
Aida Inbal & Howard JA Carp. 2007. Recurrent Pregnancy Loss. Recurrent Pregnancy Loss 127 138 .
N. TRIGUI, C. FRÈRE, C. D'ERCOLE, H. CHAMBOST, N. CHAPUIS, C. POUYMAYOU, P. MORANGE & P. DE MAZANCOURT. (2007) Molecular characterization of a novel mutation in the factor XIII A subunit gene associated with a severe defect and an adulthood diagnosis. Haemophilia 13:2, pages 221-222.
Crossref
Rima Dardik, Tanya Krapp, Esther Rosenthal, Joseph Loscalzo & Aida Inbal. (2007) Effect of FXIII on Monocyte and Fibroblast Function. Cellular Physiology and Biochemistry 19:1-4, pages 113-120.
Crossref
David Edwards, Joanne Lewis, Mark Battle, Rochelle Lear, Gill Farrar, D. Jon Barnett, Vanessa Godden, Alexandra Oliveira, Catherine Coombes & Håkan Ahlström. (2007) 99mTc-NC100668, an agent for imaging venous thromboembolism: The effect of anticoagulant or thrombolytic therapy on the uptake and retention of radioactivity in blood clots in vivo. Nuclear Medicine Communications 28:1, pages 55-62.
Crossref
Marcus Czabanka, Eike Martin & Andreas Walther. (2006) Role of Antithrombin and Factor XIII In Leukocyte-Independent Plasma Extravasation During Endotoxemia: An Intravital-Microscopic Study in the Rat. Journal of Surgical Research 136:2, pages 219-226.
Crossref
Manuela Kusch, Claudia Grundmann, Stefanie Keitel, Rainer Seitz & Herbert König. (2006) A novel assay for factor XIII based on cross-linking of synthetic peptides: analysis of different substrates. Blood Coagulation & Fibrinolysis 17:7, pages 575-580.
Crossref
Amir H. Shemirani, Gizella Haramura, Zsuzsa Bagoly & László Muszbek. (2006) The combined effect of fibrin formation and factor XIII A subunit Val34Leu polymorphism on the activation of factor XIII in whole plasma. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1764:8, pages 1420-1423.
Crossref
Jo A. Van GinderachterSofie MeerschautYuanqing LiuLea BrysKurt De GroeveGholamreza Hassanzadeh GhassabehGeert RaesPatrick De Baetselier. (2006) Peroxisome proliferator-activated receptor γ (PPARγ) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer. Blood 108:2, pages 525-535.
Crossref
Amy E. LovejoyTom C. ReynoldsJennifer E. VisichMichael D. ButineGuy YoungMelissa A. BelvedereRachelle C. BlainSusan M. PedersonLaura M. IshakDiane J. Nugent. (2006) Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency. Blood 108:1, pages 57-62.
Crossref
Yusuke Inoue, Luanne L. Peters, Sun Hee Yim, Junko Inoue & Frank J. Gonzalez. (2005) Role of hepatocyte nuclear factor 4α in control of blood coagulation factor gene expression. Journal of Molecular Medicine 84:4, pages 334-344.
Crossref
Yu-Lin Ko, Lung-An Hsu, Tsu-Shiu Hsu, Chia-Ti Tsai, Ming-Sheng Teng, Semon Wu, Chi-Jen Chang & Ying-Shiung Lee. (2005) Functional polymorphisms of FGA, encoding α fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population. Human Genetics 119:1-2, pages 84-91.
Crossref
R. DARDIK, J. LOSCALZO & A. INBAL. (2006) Factor XIII (FXIII) and angiogenesis. Journal of Thrombosis and Haemostasis 4:1, pages 19-25.
Crossref
W. Onland, A. N. Boing, A. B. Meijer, M. C. L. Schaap, R. Nieuwland, K. Haasnoot, A. Sturk & M. Peters. (2005) Congenital deficiency of factor XIII caused by two missense mutations in a Dutch family. Haemophilia 11:5, pages 539-547.
Crossref
Alessio Albanese, Antonio Tuttolomondo, Carmelo Anile, Giovanni Sabatino, Angelo Pompucci, Antonio Pinto, Guiseppe Licata & Annunziato Mangiola. (2005) Spontaneous chronic subdural hematomas in young adults with a deficiency of coagulation factor XIII. Journal of Neurosurgery 102:6, pages 1130-1132.
Crossref
E. J. Dunn, R. A. S. Ariëns & P. J. Grant. (2005) The influence of type 2 diabetes on fibrin structure and function. Diabetologia 48:6, pages 1198-1206.
Crossref
. 2005. Cardiovascular Disease. Cardiovascular Disease 312 370 .
Rima DardikJoseph LoscalzoRegina EskaraevAida Inbal. (2005) Molecular Mechanisms Underlying the Proangiogenic Effect of Factor XIII. Arteriosclerosis, Thrombosis, and Vascular Biology 25:3, pages 526-532.
Crossref
Amir Inbal, Aharon Lubetsky, Tanya Krapp, David Caste, Aviv Shaish, Gerhardt Dickneitte, Laszlo Modis, Laszlo Muszbek & Aida Inbal. (2017) Impaired wound healing in factor XIII deficient mice. Thrombosis and Haemostasis 94:08, pages 432-437.
Crossref
Duncan J. Parry, Peter J. Grant & D. Julian A. Scott. (2004) Atherothrombotic risk factor clustering in healthy male relatives of male patients with intermittent claudication. Journal of Vascular Surgery 40:5, pages 891-898.
Crossref
A. Vysokovsky, R. Saxena, M. Landau, A. Zivelin, R. Eskaraev, N. Rosenberg, U. Seligsohn & A. Inbal. (2004) Seven novel mutations in the factor XIII A‐subunit gene causing hereditary factor XIII deficiency in 10 unrelated families. Journal of Thrombosis and Haemostasis 2:10, pages 1790-1797.
Crossref
Jeffrey I. Weitz, Jack Hirsh & Meyer M. Samama. (2004) New Anticoagulant Drugs. Chest 126:3, pages 265S-286S.
Crossref
Francisco Marín, Javier Corral, Vanessa Roldán, Rocío González-Conejero, María Luz del Rey, Francisco Sogorb, Gregory Y.H. Lip & Vicente Vicente. (2004) Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation. Journal of Molecular and Cellular Cardiology 37:3, pages 699-704.
Crossref
R.A.S. Ariëns. (2004) Cross‐linked γ‐chains in a fibrin fibril are situated transversely between its strands. Journal of Thrombosis and Haemostasis 2:8, pages 1471-1473.
Crossref
Phil Stephens, Pascale Grenard, Pascale Aeschlimann, Martin Langley, Emma Blain, Rachael Errington, David Kipling, David Thomas & Daniel Aeschlimann. (2004) Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses. Journal of Cell Science 117:15, pages 3389-3403.
Crossref
Suhasini Kulkarni & Shaun P. Jackson. (2004) Platelet Factor XIII and Calpain Negatively Regulate Integrin αIIbβ3 Adhesive Function and Thrombus Growth. Journal of Biological Chemistry 279:29, pages 30697-30706.
Crossref
Nobuo OkumuraOleg V. GorkunFumiko TerasawaSusan T. Lord. (2004) Substitution of the γ-chain Asn308 disturbs the D:D interface affecting fibrin polymerization, fibrinopeptide B release, and FXIIIa-catalyzed cross-linking. Blood 103:11, pages 4157-4163.
Crossref
Amir H. Shemirani & László Muszbek. (2004) Rapid detection of the factor XIII Val34Leu (163 G→T) polymorphism by real-time PCR using fluorescence resonance energy transfer detection and melting curve analysis. Clinical Chemistry and Laboratory Medicine (CCLM) 42:8.
Crossref
Kristina F. StandevenPeter J. GrantAngela M. CarterThomas ScheinerJohn W. WeiselRobert A.S. Ariëns. (2003) Functional Analysis of the Fibrinogen Aα Thr312Ala Polymorphism. Circulation 107:18, pages 2326-2330.
Crossref
Georg Endler & Christine Mannhalter. (2003) Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clinica Chimica Acta 330:1-2, pages 31-55.
Crossref
Sofia Ramström, Mats Rånby & Tomas L Lindahl. (2003) Effects of inhibition of P2Y1 and P2Y12 on whole blood clotting, coagulum elasticity and fibrinolysis resistance studied with free oscillation rheometry. Thrombosis Research 109:5-6, pages 315-322.
Crossref
Zsuzsanna Bereczky, Ëva Katona & Läszlö Muszbek. (2003) Fibrin Stabilization (Factor XIII), Fibrin Structure and Thrombosis. Pathophysiology of Haemostasis and Thrombosis 33:5-6, pages 430-437.
Crossref
G. Pernod, C. Barro, B. Arnutti, F. Blanc-Jouvan, S. Garrel, P. Kahn, L. Minotti, A. Koudsie, A. L. Benabid, I. Wrobleski, A. Joannard & B. Polack. (2003) Surgery in severe factor XIII deficiency: report of a case of epilepsy neurosurgery and review. Haemophilia 9:1, pages 121-124.
Crossref
Aldo da Cunha Medeiros, Anísio Virgolino da Silva, Francisco Pignataro Lima, Carolina Vannucci Vasconcelos, Lidiane Maria de Brito Macedo & Nara Medeiros Cunha Melo. (2002) Efeito do fator XIII da coagulação na cicatrização da pele de ratos em uso de corticosteróide. Revista do Colégio Brasileiro de Cirurgiões 29:6, pages 324-329.
Crossref
Rudolf Pihusch, Christoph Salat, Peter Göhring, Markus Hentrich, Holger Wegner, Markus Pihusch, Erhard Hiller, Hans-Jochem Kolb & Helmut Ostermann. (2002) Factor XIII activity levels in patients with allogeneic haematopoietic stem cell transplantation and acute graft-versus-host disease of the gut. British Journal of Haematology 117:2, pages 469-476.
Crossref
Miklós Sárdy, Sarolta Kárpáti, Barbara Merkl, Mats Paulsson & Neil Smyth. (2002) Epidermal Transglutaminase (TGase 3) Is the Autoantigen of Dermatitis Herpetiformis. The Journal of Experimental Medicine 195:6, pages 747-757.
Crossref
Nena AleksicChul AhnYao-Wei WangHarinder JunejaAaron R. FolsomEric BoerwinkleKenneth K. Wu. (2002) Factor XIIIA Val34Leu Polymorphism Does Not Predict Risk of Coronary Heart Disease. Arteriosclerosis, Thrombosis, and Vascular Biology 22:2, pages 348-352.
Crossref
R. Dardik, B. Shenkman, I. Tamarin, R. Eskaraev, J. Harsfalvi, D. Varon & A. Inbal. (2002) Factor XIII mediates adhesion of platelets to endothelial cells through αvβ3 and glycoprotein IIb/IIIa integrins. Thrombosis Research 105:4, pages 317-323.
Crossref
Eckhard Stüber, Rainer Noth, Maren Dirks, Thomas Arendt & Ullrich Fölsch. (2002) The Role of Tissue Transglutaminase (Transglutaminase Type II) for the Intestinal Manifestations of Murine Semi-allogenic Graft-versus-Host Disease. Journal of Autoimmunity 18:1, pages 1-8.
Crossref
Robert A.S. Ariëns & Peter J. Grant. 2002. Wiley Encyclopedia of Molecular Medicine. Wiley Encyclopedia of Molecular Medicine.
George L. Dale, Paul Friese, Peter Batar, Stephen F. Hamilton, Guy L. Reed, Kenneth W. Jackson, Kenneth J. Clemetson & Lorenzo Alberio. (2002) Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 415:6868, pages 175-179.
Crossref
J. R. Siewert & W. HartelA. Dignass. 2002. Digitale Revolution in der Chirurgie. Digitale Revolution in der Chirurgie 850 855 .
Rendrik F. Franco & Pieter H. Reitsma. (2001) Gene polymorphisms of the haemostatic system and the risk of arterial thrombotic disease. British Journal of Haematology 115:3, pages 491-506.
Crossref
Leslie Berry, Maureen Andrew & Anthony Chan. 2001. Polymeric Biomaterials, Revised and Expanded. Polymeric Biomaterials, Revised and Expanded.
S.J. Hollingsworth, M. Dialysis & S.G.E. Barker. (2001) ««Long Haul»» Flight and Deep Vein Thrombosis: a Model to Help Investigate the Benefit of Aspirin and Below-knee Compression Stockings. European Journal of Vascular and Endovascular Surgery 22:5, pages 456-462.
Crossref
R. Wang, Z. Liang, M. Hall & K. Söderhäll. (2001) A transglutaminase involved in the coagulation system of the freshwater crayfish, Pacifastacus leniusculus. Tissue localisation and cDNA cloning. Fish & Shellfish Immunology 11:7, pages 623-637.
Crossref
Andrew J. Catto. (2001) Genetic aspects of the hemostatic system in cerebrovascular disease. Neurology 57:suppl_2.
Crossref
Sergey S. AkimovAlexey M. Belkin. (2001) Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 98:5, pages 1567-1576.
Crossref
Ryoichi Mandai, Yutaka Eguchi, Motoshi Tanaka, Yoshikazu Sai & Shuichi Nosaka. (2001) Effects of Profound Hemodilution on Small-Intestinal Wound Healing in Rabbits. Journal of Surgical Research 99:1, pages 107-113.
Crossref
Marianne Wilmer, Karin Rudin, Hans-Jürgen Kolde, Bernd Poetzsch, Wolfgang Lenz, Georg Moessmer, Esther Meili, Roland Egbring, Patrizia Gempeler-Messina, Mathias Gempeler, Sonja Bastian & Hans-Peter Kohler. (2001) Evaluation of a Sensitive Colorimetric FXIII Incorporation Assay. Effects of FXIII Val34Leu, Plasma Fibrinogen Concentration and Congenital FXIII Deficiency. Thrombosis Research 102:1, pages 81-91.
Crossref
Yutaka Furutani, Akira Kato, Michitaka Notoya, Magdy A. Ghoneim & Shigehisa Hirose. (2016) A Simple Assay and Histochemical Localization of Transglutaminase Activity Using a Derivative of Green Fluorescent Protein as Substrate. Journal of Histochemistry & Cytochemistry 49:2, pages 247-258.
Crossref
Jeffrey I. Weitz & Jack Hirsh. (2001) New Anticoagulant Drugs. Chest 119:1, pages 95S-107S.
Crossref
Barry W Festoff, Zhiming Suo & Bruce A Citron. 2001. 153 177 .
D. Girelli, O. Olivieri & R. Corrocher. 2001. Cardiovascular Genetics for Clinicians. Cardiovascular Genetics for Clinicians 71 87 .
Levente Kárpáti, Botond Penke, Éva Katona, István Balogh, György Vámosi & László Muszbek. (2000) A Modified, Optimized Kinetic Photometric Assay for the Determination of Blood Coagulation Factor XIII Activity in Plasma. Clinical Chemistry 46:12, pages 1946-1955.
Crossref
Reiko Inada, Masato Matsuki, Keiko Yamada, Yoichi Morishima, Shen-Chun Shen, Nobuo Kuramoto, Hirokazu Yasuno, Kenzo Takahashi, Yoshiki Miyachi & Kiyofumi Yamanishi. (2000) Facilitated Wound Healing by Activation of the Transglutaminase 1 Gene. The American Journal of Pathology 157:6, pages 1875-1882.
Crossref
M. F. Loreto, Massimo De Martinis, M. P. Corsi, M. Modesti & L. Ginaldi. (2000) Coagulation and cancer: Implications for diagnosis and management. Pathology & Oncology Research 6:4, pages 301-312.
Crossref
Chittalakkottu Sadasivan & Vivien C. Yee. (2000) Interaction of the Factor XIII Activation Peptide with α-Thrombin. Journal of Biological Chemistry 275:47, pages 36942-36948.
Crossref
Burgi Recheis, Andreas Osanger, Sabine Haubenwallner, Wolfgang J. Schneider & Johannes Nimpf. (2000) Chicken Coagulation Factor XIIIA Is Produced by the Theca Externa and Stabilizes the Ovarian Follicular Wall. Journal of Biological Chemistry 275:45, pages 35320-35327.
Crossref
S.-A Mahoney, M Wilkinson, S Smith & L.W Haynes. (2000) Stabilization of neurites in cerebellar granule cells by transglutaminase activity: identification of midkine and galectin-3 as substrates. Neuroscience 101:1, pages 141-155.
Crossref
Brian R. RobinsonAiilyan K. HoungGuy L. Reed. (2000) Catalytic Life of Activated Factor XIII in Thrombi. Circulation 102:10, pages 1151-1157.
Crossref
Angela M. CarterAndrew J. CattoHans P. KohlerRobert A. S. AriënsMax H. SticklandPeter J. Grant. (2000) α-Fibrinogen Thr312Ala polymorphism and venous thromboembolism. Blood 96:3, pages 1177-1179.
Crossref
Angela M. CarterAndrew J. CattoHans P. KohlerRobert A. S. AriënsMax H. SticklandPeter J. Grant. (2000) α-Fibrinogen Thr312Ala polymorphism and venous thromboembolism. Blood 96:3, pages 1177-1179.
Crossref
Robert W. Bradford, Chairman & Curriculum Oversight. (2020) High Resolution Optical Microscopy Will Play a Major Role in Functional Assessments and the Prevention of Disease. Microscopy and Microanalysis 6:S2, pages 834-835.
Crossref
David A. LanePeter J. Grant. (2000) Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 95:5, pages 1517-1532.
Crossref
Rashida Anwar & Krzysztof J. A. Miloszewski. (2008) FACTOR XIII DEFICIENCY. British Journal of Haematology 107:3, pages 468-484.
Crossref
Gang An, C.S.Reddy Meka, Steven P Bright & Robert W Veltri. (1999) Human prostate-specific transglutaminase gene: promoter cloning, tissue-specific expression, and down-regulation in metastatic prostate cancer. Urology 54:6, pages 1105-1111.
Crossref
Einar Jörundsson, Charles McL Press & Thor Landsverk. (1999) Factor XIIIa positive dendritic cells are a major accessory cell population in the elicitation phase of DNCB-induced contact hypersensitivity. Veterinary Immunology and Immunopathology 71:2, pages 99-113.
Crossref
Peter J. Grant & Steven E. Humphries. (1999) Genetic determinants of arterial thrombosis. Best Practice & Research Clinical Haematology 12:3, pages 505-532.
Crossref
R. A. S. AriënsH. P. KohlerM. W. MansfieldP. J. Grant. (1999) Subunit Antigen and Activity Levels of Blood Coagulation Factor XIII in Healthy Individuals. Arteriosclerosis, Thrombosis, and Vascular Biology 19:8, pages 2012-2016.
Crossref
Angela M. CarterAndrew J. CattoPeter J. Grant. (1999) Association of the α-Fibrinogen Thr312Ala Polymorphism With Poststroke Mortality in Subjects With Atrial Fibrillation. Circulation 99:18, pages 2423-2426.
Crossref
Thomas Noll, Gernold Wozniak, Karin McCarson, Amir Hajimohammad, Hubert J. Metzner, Javier Inserte, Wolfgang Kummer, Friedrich Wilhelm Hehrlein & Hans Michael Piper. (1999) Effect of Factor XIII on Endothelial Barrier Function. The Journal of Experimental Medicine 189:9, pages 1373-1382.
Crossref
Belsy Guerrero, Jonas Perales, Amparo Gil & Carmen Luisa Arocha-Piñango. (1999) Effect on Platelet FXIII and Partial Characterization of Lonomin V, a Proteolytic Enzyme from Lonomia achelous Caterpillars. Thrombosis Research 93:5, pages 243-252.
Crossref
Gernold Wozniak, Thomas Noll, Friedhelm Dapper, Hans Piper & Friedrich Hehrlein. (2011) Experimental approach to improve endothelial barrier function in myocardium. International Journal of Angiology 8:02, pages 119-123.
Crossref
Brian A. Fox, Vivien C. Yee, Lars C. Pedersen, Isolde Le Trong, Paul D. Bishop, Ronald E. Stenkamp & David C. Teller. (1999) Identification of the Calcium Binding Site and a Novel Ytterbium Site in Blood Coagulation Factor XIII by X-ray Crystallography. Journal of Biological Chemistry 274:8, pages 4917-4923.
Crossref
Kira S. Makarova, L. Aravind & Eugene V. Koonin. (2008) A superfamily of archaeal, bacterial, and eukaryotic proteins homologous to animal transglutaminases. Protein Science 8:8, pages 1714-1719.
Crossref
Alon Monsonego, Tal Mizrahi, Shoshana Eitan, Gila Moalem, Helga Bárdos, Róza Ádány & Michal Schwartz. (1998) Factor XIIIa as a nerve‐associated transglutaminase. The FASEB Journal 12:12, pages 1163-1171.
Crossref
Anne M. RomanicAnthony J. ArlethRobert N. WilletteEliot H. Ohlstein. (1998) Factor XIIIa Cross-links Lipoprotein(a) With Fibrinogen and Is Present in Human Atherosclerotic Lesions. Circulation Research 83:3, pages 264-269.
Crossref
Manfred S Weiss, Hubert J Metzner & Rolf Hilgenfeld. (1998) Two non-proline cis peptide bonds may be important for factor XIII function . FEBS Letters 423:3, pages 291-296.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.